Ergocalciferol

维生素D2

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameErgocalciferol
Drug Alias Name麦角钙化醇ergocalciferolumergocalciferol麦角沈钙醇Vitamin D2 +[10] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsMultiple TraumaBurnsChronic Pain +[23] 
Global Approved IndicationsHypothyroidismHypoparathyroidismHypophosphatemia +[7] 
Approved Indications in ChinaHypoparathyroidismHypocalcemiaHypophosphatemia, Familial +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date1941/01/11
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAllegheny Singer Research InstituteUniversity Of North Carolina At Chapel HillUs Pharm Holdings +[4] 
Inactive CompaniesUtah State UniversityThe Brigham and Women's HospitalTexas Tech University Health Sciences Center +[8] 
Active IndicationsBurnsChronic PainHypothyroidism +[11] 
Inactive IndicationsMultiple TraumaInflammationHyperparathyroidism +[12] 

Other Information

ATC CodeA11CC01
Related LinksWikipediaDrugBankKEGG